EUVIMEDEUVIMED entdecken
Crossref

Dexmedetomidine Activates AMPK/SIRT1 Pathway to Reduce Inflammatory Levels and Neuronal Pyroptosis to Alleviate Neonatal Hypoxic‐Ischemic Brain Damage

Jinping Jiang, Ling Fan, Yejun Zhao, Yanwen Wang, Minzhi He, Weinong Mo, Jianhong Li, Mengzao He

Developmental Neurobiology · 2026

DOI: 10.1002/dneu.70067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Developmental Neurobiology, 2026. Verfasst von Jinping Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, Zhejiang Province, China. Hauptthemen laut MEDLINE: Dexmedetomidine, Sirtuin 1, Pyroptosis, Neurons. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Zhejiang Medicine and Health Science and Technology Plan Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neonatal hypoxic‐ischemic brain damage (HIBD) is the leading cause of neonatal death and long‐term neurological dysfunction. Dexmedetomidine (DEX) has been shown to have neuroprotective effects, but its mechanisms in HIBD remain incompletely understood. This study aimed to explore whether DEX inhibits neuroinflammation and pyroptosis via activating adenosine monophosphate‐activated protein kinase (AMPK)/sirtuin 1 (SIRT1) axis, thereby reducing HIBD. A HIBD model was established. Histological staining observed the pathological changes and neuronal survival. Primary cortical neurons were cultured to establish an oxygen–glucose deprivation/reoxygenation (OGD/R) model. DEX was used for intervene, and siAMPK was transfected to knock down AMPK expression. Inflammatory and oxidative stress indicators within brain tissue and neuronal cells were measured using enzyme‐linked immunosorbent assay (ELISA) and biochemical kits. The AMPK/SIRT1 pathway and pyroptosis protein expressions were evaluated using fluorescence staining and Western blot. DEX dose‐dependently reduced cerebral infarction volume, improved cerebral cortex pathological damage, enhanced neuronal nuclei (NeuN) positive neurons, decreased interleukin (IL)‐6 and malondialdehyde (MDA) contents, enhanced superoxide dismutase (SOD) activity, and inhibited terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)/cleaved Caspase‐1 double positive cells and N‐terminal domain of Gasdermin D (GSDMD‐N) protein expressions. DEX significantly upregulated p‐AMPK and SIRT1 expression, whereas the AMPK inhibitor Compound C reversed the neuroprotective effect of DEX. In vitro experiments confirmed that DEX increased neuronal cell viability, reduced lactate dehydrogenase (LDH) release and propidium iodide (PI)‐positive cell rate, reduced oxidative stress, and inhibited inflammatory factor release and pyroptosis‐related protein expression. AMPK knockdown significantly reversed this axis activation by DEX and attenuated the neuroprotective effect of DEX. In conclusion, DEX improved neurological function in HIBD rats via the activating AMPK/SIRT1 pathway, reducing neuroinflammation and inhibiting neuronal pyroptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexmedetomidineSirtuin 1PyroptosisNeuronsAMP-Activated Protein KinasesHypoxia-Ischemia, BrainNeuroprotective AgentsAnimalsRatsAnimals, NewbornSignal TransductionRats, Sprague-DawleyOxidative StressInflammation

Stichwörter der Autor:innen

adenosine monophosphate‐activated protein kinase (AMPK)/sirtuin 1 (SIRT1) pathw…dexmedetomidinehypoxic‐ischemic brain damageinflammationpyroptosis

Substanzen

DexmedetomidineSirtuin 1AMP-Activated Protein KinasesNeuroprotective AgentsSirt1 protein, rat

Autor:innen und Institutionen

  • Department of Neonatology, Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, Zhejiang Province, China.
  • Department of Anesthesiology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.
  • Hangzhou Zunxiang Biotechnology Co., Ltd, Hangzhou, Zhejiang Province, China.

Förderung

  • Zhejiang Medicine and Health Science and Technology Plan Project

Zitieren

APA

Jiang, J., Fan, L., Zhao, Y., Wang, Y., He, M., Mo, W., Li, J., & He, M. (2026). Dexmedetomidine Activates AMPK/SIRT1 Pathway to Reduce Inflammatory Levels and Neuronal Pyroptosis to Alleviate Neonatal Hypoxic‐Ischemic Brain Damage. Developmental Neurobiology. https://doi.org/10.1002/dneu.70067

Vancouver

Jiang J, Fan L, Zhao Y, Wang Y, He M, Mo W, et al. Dexmedetomidine Activates AMPK/SIRT1 Pathway to Reduce Inflammatory Levels and Neuronal Pyroptosis to Alleviate Neonatal Hypoxic‐Ischemic Brain Damage. Developmental Neurobiology. 2026. doi:10.1002/dneu.70067

BibTeX
@article{Jiang2026,
  author = {Jiang, Jinping and Fan, Ling and Zhao, Yejun and Wang, Yanwen and He, Minzhi and Mo, Weinong and Li, Jianhong and He, Mengzao},
  title = {Dexmedetomidine Activates AMPK/SIRT1 Pathway to Reduce Inflammatory Levels and Neuronal Pyroptosis to Alleviate Neonatal Hypoxic‐Ischemic Brain Damage},
  journal = {Developmental Neurobiology},
  year = {2026},
  doi = {10.1002/dneu.70067}
}
Kostenlos starten →